Bridgeway Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Bridgeway Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2	Closed	-$48K	–	1453
2022 Q2	$48K	Buy	+2	New	+$148K	﹤0.01%	1283
2022 Q1	–	Hold	0	–	–	–	1306
2021 Q4	–	Hold	0	–	–	–	1258
2021 Q3	–	Hold	0	–	–	–	1281
2021 Q2	–	Hold	0	–	–	–	1242
2021 Q1	–	Hold	0	–	–	–	1202
2020 Q4	–	Hold	0	–	–	–	1222
2020 Q3	–	Hold	0	–	–	–	1159
2020 Q2	–	Hold	0	–	–	–	1179
2016 Q4	–	Hold	0	–	-$66K	–	1465
2016 Q3	–	Hold	0	–	–	–	1392
2016 Q2	–	Hold	0	–	–	–	1316
2016 Q1	–	Hold	0	–	–	–	1280
2015 Q4	–	Hold	0	–	–	–	904
2015 Q3	–	Hold	0	–	–	–	1029
2015 Q2	–	Hold	0	–	–	–	1005

Other funds holding TNXP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridgeway Capital Management's TNXP Position: Q3 2022 in Review

Bridgeway Capital Management sold out of Tonix Pharmaceuticals (TNXP) in Q3 2022, closing a stake of 2 shares — an estimated $48K sold.

Bridgeway Capital Management first reported a position in TNXP in Q2 2022 and held it in 1 quarter. The position peaked at $48K in Q2 2022. 19 funds tracked by Wall St. Rank hold TNXP as of Q3 2022.

Bridgeway Capital Management reported no remaining Tonix Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Bridgeway Capital Management sold 2 Tonix Pharmaceuticals shares in Q3 2022, an estimated $48K.
Bridgeway Capital Management first reported a position in Tonix Pharmaceuticals in Q2 2022 and held it in 1 quarter.
Bridgeway Capital Management's Tonix Pharmaceuticals position peaked at $48K in Q2 2022.
19 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2022.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.